Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction

Trial Profile

Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2013

At a glance

  • Drugs Nesiritide (Primary)
  • Indications Heart failure
  • Focus Pharmacodynamics
  • Most Recent Events

    • 11 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 11 May 2010 Planned end date (1 Jul 2010) added as reported by ClinicalTrials.gov.
    • 11 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top